111 Inc (YI)
1.33
-0.01
(-0.75%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
111 Accounts Payable (Quarterly): 224.12M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 224.12M |
September 30, 2023 | 248.72M |
June 30, 2023 | 208.56M |
March 31, 2023 | 244.31M |
December 31, 2022 | 255.80M |
September 30, 2022 | 217.22M |
June 30, 2022 | 225.41M |
March 31, 2022 | 214.98M |
December 31, 2021 | 211.38M |
September 30, 2021 | 229.94M |
June 30, 2021 | 242.01M |
March 31, 2021 | 208.56M |
Date | Value |
---|---|
December 31, 2020 | 164.29M |
September 30, 2020 | 190.82M |
June 30, 2020 | 120.29M |
March 31, 2020 | 89.64M |
December 31, 2019 | 63.51M |
September 30, 2019 | 57.87M |
June 30, 2019 | 68.38M |
March 31, 2019 | 38.37M |
December 31, 2018 | 30.86M |
September 30, 2018 | 36.00M |
June 30, 2018 | 35.31M |
December 31, 2017 | 19.63M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
57.87M
Minimum
Sep 2019
255.80M
Maximum
Dec 2022
183.46M
Average
211.38M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | 18.23M |
Sinovac Biotech Ltd | 17.29M |
CASI Pharmaceuticals Inc | 4.438M |
Zai Lab Ltd | 88.12M |
ASLAN Pharmaceuticals Ltd | 9.656M |